|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.67 USD | -0.47% |
|
-5.10% | +8.60% |
| 04-21 | UK's British Land lifts earnings forecast as AI firms flock to London campuses | RE |
| 04-20 | Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.47% | -5.10% | -2.86% | +3.24% | +8.60% | +27.76% | +53.97% | +99.57% | +31.01% | 165B | |
| +1.79% | -2.11% | -0.41% | -16.27% | -15.97% | +10.39% | +134.40% | +372.91% | +1,067.14% | 808B | |
| +0.34% | -5.81% | -3.91% | +3.74% | +9.28% | +44.12% | +39.01% | +35.76% | +99.14% | 545B | |
| +0.17% | -2.44% | +0.02% | -5.10% | -10.23% | +20.55% | +26.30% | +85.13% | +234.23% | 363B | |
| -2.20% | +0.60% | +6.35% | -7.17% | -2.50% | +25.20% | +13.86% | +0.90% | +26.38% | 325B | |
| -0.38% | -1.48% | +5.87% | +7.29% | +5.50% | +43.47% | +19.60% | +89.60% | +253.41% | 305B | |
| -0.34% | -1.88% | 0.00% | +0.89% | +5.95% | +28.05% | +29.73% | +43.06% | +55.87% | 284B | |
| -0.43% | -6.17% | -1.42% | +1.31% | +6.94% | +44.59% | -2.44% | +42.07% | +98.87% | 278B | |
| +0.13% | -1.74% | -0.85% | +0.37% | +5.36% | +26.01% | +41.42% | +33.26% | +109.83% | 186B | |
| +0.59% | -1.41% | +5.52% | -37.41% | -23.66% | -36.33% | -56.94% | +8.13% | +33.67% | 172B | |
| -0.81% | +0.74% | +1.26% | +5.48% | +9.68% | +23.91% | -32.08% | -30.91% | -17.84% | 155B | |
| -0.07% | +2.26% | +3.32% | +8.97% | +10.10% | +21.35% | -15.75% | -10.45% | -15.35% | 121B | |
| -0.12% | -0.23% | +5.32% | +1.45% | -2.18% | -11.23% | -21.30% | -6.50% | +3.07% | 115B | |
| -0.19% | -2.20% | +7.60% | +15.50% | +14.23% | +53.03% | +41.40% | +23.66% | +12.28% | 112B | |
| +0.06% | -1.73% | -3.83% | -5.32% | -3.70% | -8.57% | +31.86% | +98.67% | +402.93% | 111B | |
| +0.76% | +1.19% | +10.23% | +4.29% | +6.27% | +5.38% | +157.87% | +99.64% | +580.83% | 89.75B | |
| -3.10% | -5.94% | -4.64% | +5.79% | +9.99% | +23.67% | +17.76% | +43.42% | -3.57% | 54.39B | |
| -1.05% | -0.77% | +1.11% | -7.24% | -6.41% | +13.38% | +17.81% | -19.57% | +285.84% | 54.22B | |
| +1.09% | -0.83% | +5.03% | -8.52% | +9.16% | +88.04% | -33.15% | -27.46% | -63.37% | 46.15B | |
| -1.58% | -1.84% | -5.20% | -8.33% | -7.52% | -10.30% | -1.20% | - | - | 42.39B | |
| Average | -0.36% | -1.76% | +1.43% | -1.85% | +1.44% | +21.62% | +23.11% | +51.62% | +168.12% | 216.66B | |
| Weighted average by Cap. | -0.06% | -2.10% | +0.85% | -3.57% | -0.97% | +23.31% | +41.04% | +103.26% | +295.57% |
- Stock Market
- Equities
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition